NRP1 and pancreatic neoplasm: Having demonstrated that NRP-1 overexpression provides a survival advantage for FG cells exposed to two chemotherapeutic agents, we sought to determine whether decreased NRP-1 expression would render pancreatic cancer cells more susceptible to these drugs.